Organon (OGN) EBITDA Margin (QoQ) (2020 - 2026)
Powered by 
Analysis
Organon (OGN) EBITDA Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 464.00 |
| Mar 31, 2026 | 216.00 |
| Dec 31, 2025 | -841.00 |
| Sep 30, 2025 | 202.00 |
| Jun 30, 2025 | 453.00 |
| Mar 31, 2025 | -229.00 |
| Dec 31, 2024 | -656.00 |
| Sep 30, 2024 | 63.00 |
| Jun 30, 2024 | -9.00 |
| Mar 31, 2024 | 896.00 |
| Dec 31, 2023 | -13.00 |
| Sep 30, 2023 | -892.00 |
| Jun 30, 2023 | -117.00 |
| Mar 31, 2023 | 771.00 |
| Dec 31, 2022 | -890.00 |
| Sep 30, 2022 | -298.00 |
| Jun 30, 2022 | -487.00 |
| Mar 31, 2022 | 870.00 |
| Dec 31, 2021 | -655.00 |
| Sep 30, 2021 | -29.00 |